ZYNTEMA Trademark

Trademark Overview


On Monday, July 3, 2017, a trademark application was filed for ZYNTEMA with the United States Patent and Trademark Office. The USPTO has given the ZYNTEMA trademark a serial number of 79213742. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, December 29, 2019. This trademark is owned by Novartis AG. The ZYNTEMA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disord...
zyntema

General Information


Serial Number79213742
Word MarkZYNTEMA
Filing DateMonday, July 3, 2017
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, December 29, 2019
Registration Number5494573
Registration DateTuesday, June 19, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2017

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma, all of the foregoing excluding pharmaceutical preparations and substances for the treatment or management of sleep disorders"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, December 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Saturday, January 16, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, January 16, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, September 21, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 17, 2018NOTIFICATION PROCESSED BY IB
Tuesday, July 24, 2018FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 24, 2018FINAL DISPOSITION PROCESSED
Thursday, July 19, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 19, 2018REGISTERED-PRINCIPAL REGISTER
Monday, May 14, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, May 9, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, May 7, 2018ASSIGNED TO PETITION STAFF
Monday, April 23, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, November 30, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 31, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2017NOTICE OF PUBLICATION
Friday, September 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 14, 2017ASSIGNED TO EXAMINER
Wednesday, August 23, 2017UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, August 11, 2017APPLICATION FILING RECEIPT MAILED
Monday, August 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 4, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 3, 2017SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB